Clinical Trials Directory

Trials / Unknown

UnknownNCT02374632

Gut Hormones as Mediators of Different Weight Loss Responses After Roux-en-Y Gastric Bypass

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Hvidovre University Hospital · Academic / Other
Sex
All
Age
20 Years – 75 Years
Healthy volunteers
Not accepted

Summary

After gastric bypass, 10-20% of patients will obtain a suboptimal weight loss, often defined as \<50% of the excess body weight. Exaggerated meal related secretion of gut hormones seem important for appetite reduction and subsequent weight loss after gastric bypass, however it is not clear whether different gut hormone responses are responsible for different postoperative weight loss responses. The purpose of the study is to investigate gut hormone secretion, vagal integrity and the effect of octreotide on ad libitum food intake in patients with suboptimal weight loss after gastric bypass and compare results to a matched group of gastric bypass operated patients with high postoperative weight loss but similar age, sex and preoperative BMI.

Conditions

Interventions

TypeNameDescription
OTHERMeal tests after saline injectionFixed breakfast meal and ad libitum lunch meal
OTHERMeal tests after octreotide injectionFixed breakfast meal and ad libitum lunch meal
OTHERSham feeding

Timeline

Start date
2014-10-01
Primary completion
2016-12-01
Completion
2017-06-01
First posted
2015-03-02
Last updated
2017-02-07

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT02374632. Inclusion in this directory is not an endorsement.